Cargando…
Hypomethylation status of miR-657 promoter region as biomarker for diagnosis of hepatocellular carcinoma: a retrospective study
BACKGROUND: The purpose of our study was to evaluate whether the methylation status of the miR-657 promoter region could be used as a biomarker for diagnosis of hepatocellular carcinoma (HCC), so as to find alternative biomarkers of early HCC detection. METHODS: Cancerous and paired adjacent noncanc...
Autores principales: | Shi, Zhaoqi, Luo, Peng, Fan, Xiaoxiao, Pan, Junhai, He, Lifeng, Zhou, Daizhan, Lin, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189178/ https://www.ncbi.nlm.nih.gov/pubmed/35706811 http://dx.doi.org/10.21037/tcr-21-2621 |
Ejemplares similares
-
Methylation patterns of RASA3 associated with clinicopathological factors in hepatocellular carcinoma
por: Lin, Hui, et al.
Publicado: (2018) -
miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction
por: Zhang, Yingqian, et al.
Publicado: (2022) -
miR-657 Promotes Macrophage Polarization toward M1 by Targeting FAM46C in Gestational Diabetes Mellitus
por: Wang, Pingping, et al.
Publicado: (2019) -
The association between methylation patterns of DNAH17 and clinicopathological factors in hepatocellular carcinoma
por: Fan, Xiaoxiao, et al.
Publicado: (2018) -
657. Diagnostic Utility of Dedicated Fungal Blood Cultures for Diagnosis of Candidemia
por: Yang, Bryant, et al.
Publicado: (2020)